Ramaco Resources enters the back half of August carrying a sharp divergence between its 13% weekly bounce and a fresh wave of analyst target cuts — a tension that makes this week's setup notably charged.
The options market flagged caution loudest on Tuesday. The put/call ratio jumped to 0.56, more than three standard deviations above its 20-day average of 0.33 — the most defensive single-day reading in weeks and a sharp departure from a PCR that had run below 0.37 every day for the prior two weeks. That spike lands the day after the stock fell 5.2% to $11.60, and just over a week after earnings delivered a 10.8% one-day gain and a 14% five-day run. Options traders, it seems, are not chasing the momentum — they are hedging against it unwinding before the November 6 results.
Short interest reinforces that the stock remains genuinely contested. Bears hold 23.5% of the free float — well into elevated territory — and that position grew roughly 3.8% on the week even as the stock rallied. Yet the borrow market tells a more relaxed story than the headline figure implies. Cost to borrow is running at just 0.53%, a low rate that has actually eased about 7% on the week. Availability has loosened sharply too: at 71% it has climbed back from a trough of just 29% in early August, when the lending pool was close to fully subscribed. The ORTEX short score of 76.8 — ranked in the bottom 1% of the universe on that factor — confirms sustained bearish conviction, but the easing borrow conditions suggest new short sellers are not racing to pile in at these levels.
The Street has turned markedly more cautious in the past two weeks. Morgan Stanley lowered its target to $11 on Tuesday while keeping an Equal-Weight rating — meaning the current price and the target are now essentially the same. Baird went further, downgrading to Neutral from Outperform, a more decisive change of view. Goldman Sachs cut to $11 earlier this month, matching the stock's close almost exactly. Benchmark remains the outlier bull with a Buy rating and a $26 target, but even Benchmark trimmed that from $38 in early August. The consensus mean target of $18.88 implies significant upside on paper, though the recent cluster of cuts at $11-$13 from three separate firms suggests that figure is being pulled down fast. EPS momentum is ranked near the bottom of the universe — 3rd percentile on a 30-day basis — and the stock's PE is deeply negative, reflecting losses rather than earnings compression.
The insider and institutional flow adds another layer of selling pressure. Discovery Capital, the second-largest holder at 7.8% of shares, sold 500,000 shares at $9.57 on August 6 — a $4.8m transaction registered as an insider trade given its status as a 10% owner. That sale came at the stock's recent lows, just before the earnings bounce, and Discovery's total holding has since declined. Millennium Management entered a large position earlier this year but that data runs to end-March. BlackRock added 700,000 shares through July, making it the third-largest holder alongside Discovery, a counterweight to the selling pressure from the 10% owner cluster.
The nearest peers had a quieter week. HCC was roughly flat on the week while AMR gained about 10% — suggesting METC's bounce was partly stock-specific rather than a pure sector re-rating. With next earnings not until November 6, the key variable to watch is whether the avalanche of analyst target reductions — now converging around the current price — stabilises or accelerates as met coal pricing data filters through the sector.
See the live data behind this article on ORTEX.
Open METC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
